314 related articles for article (PubMed ID: 12032632)
1. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
2. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Hum Hypertens; 2002 Aug; 16(8):539-47. PubMed ID: 12149659
[TBL] [Abstract][Full Text] [Related]
3. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Shouzu A; Urase F; Maeda Y
Platelets; 2009 Sep; 20(6):406-14. PubMed ID: 19658004
[TBL] [Abstract][Full Text] [Related]
4. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer.
Kanazawa S; Nomura S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
Lung Cancer; 2003 Feb; 39(2):145-9. PubMed ID: 12581566
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
Thromb Res; 2005; 115(4):277-85. PubMed ID: 15668187
[TBL] [Abstract][Full Text] [Related]
7. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Diabetes Complications; 2003; 17(3):153-9. PubMed ID: 12738400
[TBL] [Abstract][Full Text] [Related]
8. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
J Hum Hypertens; 2005 Jul; 19(7):551-7. PubMed ID: 15829999
[TBL] [Abstract][Full Text] [Related]
9. Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia.
Nomura S; Inami N; Ozaki Y; Kagawa H; Fukuhara S
Platelets; 2008 May; 19(3):192-8. PubMed ID: 18432520
[TBL] [Abstract][Full Text] [Related]
10. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
11. [Platelet activation marker].
Nomura S
Rinsho Byori; 2003 Nov; 51(11):1096-101. PubMed ID: 14679788
[TBL] [Abstract][Full Text] [Related]
12. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
[TBL] [Abstract][Full Text] [Related]
13. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
14. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.
Pawelczyk M; Baj Z; Chmielewski H; Kaczorowska B; Klimek A
Cerebrovasc Dis; 2009; 27(2):131-7. PubMed ID: 19047793
[TBL] [Abstract][Full Text] [Related]
15. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
Thromb Res; 2006; 117(4):385-92. PubMed ID: 15896827
[TBL] [Abstract][Full Text] [Related]
16. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
Tarnow I; Michelson AD; Barnard MR; Frelinger AL; Aasted B; Jensen BR; Parving HH; Rossing P; Tarnow L
Platelets; 2009 Nov; 20(7):513-9. PubMed ID: 19852691
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin.
Tamagawa-Mineoka R; Katoh N; Kishimoto S
J Am Acad Dermatol; 2010 Apr; 62(4):621-6. PubMed ID: 19962788
[TBL] [Abstract][Full Text] [Related]
18. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy.
Ogata N; Nomura S; Shouzu A; Imaizumi M; Arichi M; Matsumura M
Diabetes Res Clin Pract; 2006 Sep; 73(3):241-8. PubMed ID: 16584800
[TBL] [Abstract][Full Text] [Related]
19. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
